Soluble Toll-like receptor 2 is significantly elevated in HIV-1 infected breast milk and inhibits HIV-1 induced cellular activation, inflammation and infection

AIDS

Volumn 28, Issue 14, 2014, Pages 2023-2032

  Henrick, Bethany M ^a   Yao, Xiao Dan ^a   Drannik, Anna G ^a   Abimiku, Alash'le ^b   Rosenthal, Kenneth L ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Breast milk; Cellular activation; Gp120; Gp41; HIV; Inflammation; Innate immunity; P17; P24; Soluble Toll like receptor 2

Indexed keywords

ANTIGEN P24; CHEMOKINE RECEPTOR CCR5; CYTOKINE; GLYCOPROTEIN GP 41; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 15; INTERLEUKIN 8; PROTEIN P17; TOLL LIKE RECEPTOR 2; CD27 ANTIGEN; COL11A1 PROTEIN, HUMAN; COLLAGEN TYPE 11;

ADULT; ARTICLE; BREAST EPITHELIUM; BREAST MILK; CANADIAN; CELL ACTIVATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IN VITRO STUDY; INFLAMMATION; INNATE IMMUNITY; MACROPHAGE; NIGERIAN; PRIORITY JOURNAL; VERTICAL TRANSMISSION; VIRUS INHIBITION; BREAST FEEDING; CANADA; CELL LINE; CHEMISTRY; CLINICAL TRIAL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; METABOLISM; MULTICENTER STUDY; NEWBORN; NIGERIA; PREGNANCY; PREVENTION AND CONTROL; TRANSMISSION; WESTERN BLOTTING;

ADULT; ANTIGENS, CD27; BLOTTING, WESTERN; BREAST FEEDING; CANADA; CELL LINE; COLLAGEN TYPE XI; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY, INNATE; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; INFLAMMATION; MILK, HUMAN; NIGERIA; PREGNANCY;

EID: 84906766051     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000381     Document Type: Article

References (40)

1. Coovadia HM, Rollins NC, Bland RM, Little K, Coutsoudis A, Bennish ML, et al. Mother-To-child transmission of HIV-1 infection during exclusive breastfeeding in the first 6 months of life: an intervention cohort study. Lancet 2007; 369: 1107-1116.
2. Kuhn L, Sinkala M, Kankasa C, Semrau K, Kasonde P, Scott N, et al. High uptake of exclusive breastfeeding and reduced early postnatal HIV transmission. PLoS One 2007; 2: e1363.
3. Iliff PJ, Piwoz EG, Tavengwa NV, Zunguza CD, Marinda ET, Nathoo KJ, et al. Early exclusive breastfeeding reduces the risk of postnatal HIV-1 transmission and increases HIV-free survival. AIDS 2005; 19: 699-708.
4. Coutsoudis A, Kuhn L, Pillay K, Coovadia HM. Exclusive breastfeeding and HIV transmission. AIDS 2002; 16: 498-499.
5. Kazmi SH, Naglik JR, Sweet SP, Evans RW, O'Shea S, Banatvala JE, et al. Comparison of human immunodeficiency virus type 1-specific inhibitory activities in saliva and other human mucosal fluids. Clin Vaccine Immunol 2006; 13: 1111-1118.
6. Lyimo MA, Howell AL, Balandya E, Eszterhas SK, Connor RI. Innate factors in human breast milk inhibit cell-free HIV-1 but not cell-Associated HIV-1 infection of CD4R cells. J Acquir Immune Defic Syndr 2009; 51: 117-124.
7. Saeland E, de Jong MAWP, Nabatov AA, Kalay H, Geijtenbeek TBH, van Kooyk Y. MUC1 in human milk blocks transmission of human immunodeficiency virus from dendritic cells to T cells. Mol Immunol 2009; 46: 2309-2316.
8. Groot F, Geijtenbeek TBH, Sanders RW, Baldwin CE, Sanchez-Hernandez M, Floris R, et al. Lactoferrin prevents dendritic cellmediated human immunodeficiency virus type 1 transmission by blocking the DC-SIGN-gp120 interaction. J Virol 2005; 79: 3009-3015.
9. Henrick BM, Nag K, Yao X-D, Drannik AG, Aldrovandi GM, Rosenthal KL. Milk matters: soluble Toll-like receptor 2 (sTLR2) in breast milk significantly inhibits HIV-1 infection and inflammation. PLoS One 2012; 7: e40138.
10. Liew FY, Xu D, Brint EK, O'Neill LAJ. Negative regulation of toll-like receptor-mediated immune responses. Nat Rev Immunol 2005; 5: 446-458.
11. LeBouder E, Rey-Nores JE, Rushmere NK, Grigorov M, Lawn SD, Affolter M, et al. Soluble forms of Toll-like receptor (TLR)2 capable of modulating TLR2 signaling are present in human plasma and breast milk. J Immunol 2003; 171: 6680-6689.
12. Kuroishi T, Tanaka Y, Sakai A, Sugawara Y, Komine K-I, Sugawara S. Human parotid saliva contains soluble toll-like receptor (TLR) 2 and modulates TLR2-mediated interleukin-8 production by monocytic cells. Mol Immunol 2007; 44: 1969-1976.
13. Dulay AT, Buhimschi CS, Zhao G, Oliver EA, Mbele A, Jing S, et al. Soluble TLR2 is present in human amniotic fluid and modulates the intraamniotic inflammatory response to infection. J Immunol 2009; 182: 7244-7253.
14. DeVico AL, Gallo RC. Control of HIV-1 infection by soluble factors of the immune response. Nat Rev Microbiol 2004; 2: 401-413.
15. Drannik AG, Nag K, Yao X-D, Henrick BM, Sallenave J-M, Rosenthal KL. Trappin-2/elafin modulate innate immune responses of human endometrial epithelial cells to PolyI: C. PLoS One 2012; 7: e35866.
16. Boehme KW, Guerrero M, Compton T. Human cytomegalovirus envelope glycoproteins B and H are necessary for TLR2 activation in permissive cells. J Immunol 2006; 177: 7094-7102.
17. Dolganiuc A, Oak S, Kodys K, Golenbock DT, Finberg RW, Kurt-Jones E, et al. Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation. Gastroenterology 2004; 127: 1513-1524.
18. Bieback K, Lien E, Klagge IM, Avota E, Schneider-Schaulies J, Duprex WP, et al. Hemagglutinin protein of wild-Type measles virus activates toll-like receptor 2 signaling. J Virol 2002; 76: 8729-8736.
19. Mogensen TH, Melchjorsen J, Larsen CS, Paludan SR. Innate immune recognition and activation during HIV infection. Retrovirology 2010; 7: 54.
20. Heggelund L, Müller F, Lien E, Yndestad A, Ueland T, Kristiansen KI, et al. Increased expression of toll-like receptor 2 on monocytes in HIV infection: possible roles in inflammation and viral replication. Clin Infect Dis 2004; 39: 264-269.
21. Lester RT, Yao X-D, Ball TB, McKinnon LR, Kaul R, Wachihi C, et al. Toll-like receptor expression and responsiveness are increased in viraemic HIV-1 infection. AIDS 2008; 22: 685-694.
22. Mian MF, Ahmed AN, Rad M, Babaian A, Bowdish D, Ashkar AA. Length of dsRNA (poly I: C) drives distinct innate immune responses, depending on the cell type. J Leukoc Biol 2013; 94: 1025-1036.
23. Matucci A, Rossolillo P, Baroni M, Siccardi AG, Beretta A, Zipeto D. HLA-C increases HIV-1 infectivity and is associated with gp120. Retrovirology 2008; 5: 68.
24. Leoni V, Gianni T, Salvioli S, Campadelli-Fiume G. Herpes simplex virus glycoproteins gH/gL and gB bind Toll-like receptor 2, and soluble gH/gL is sufficient to activate NF-kB. J Virol 2012; 86: 6555-6562.
25. Yao XD, Omange RW, Henrick BM, Lester RT, Kimani J, Ball TB, et al. Acting locally: innate mucosal immunity in resistance to HIV-1 infection in Kenyan commercial sex workers. Mucosal Immunol 2014; 7: 268-279.
26. Ding J, Rapista A, Teleshova N, Mosoyan G, Jarvis GA, Klotman ME, et al. Neisseria gonorrhoeae enhances HIV-1 infection of primary resting CD4R T cells through TLR2 activation. J Immunol 2010; 184: 2814-2824.
27. Hernandez JC, Stevenson M, Latz E, Urcuqui Inchima S. HIV-1 infection up-regulates TLR2 and TLR4 expression and function in vivo and in vitro. AIDS Res Hum Retroviruses 2012; 28: 1313-1328.
28. Goldman AS. Human milk, leukocytes, and immunity. J Pediatr 1977; 90: 167-168.
29. Jain N, Mathur NB, Sharma VK, Dwarkadas AM. Cellular composition including lymphocyte subsets in preterm and full term human colostrum and milk. Acta Paediatr Scand 1991; 80: 395-399.
30. Satomi M, Shimizu M, Shinya E, Watari E, Owaki A, Hidaka C, et al. Transmission of macrophage-Tropic HIV-1 by breast-milk macrophages via DC-SIGN. J Infect Dis 2005; 191: 174-181.
31. Bosire R, John-Stewart GC, Mabuka JM, Wariua G, Gichuhi C, Wamalwa D, et al. Breast milk defensins are associated with HIV type 1 RNA and CC chemokines in breast milk but not vertical HIV type 1 transmission. AIDS Res Hum Retroviruses 2007; 23: 198-203.
32. Heggelund L, Flo T, Berg K, Lien E, Mollnes TE, Ueland T, et al. Soluble toll-like receptor 2 in HIV infection: association with disease progression. AIDS 2004; 18: 2437-2439.
33. Walter J, Ghosh MK, Kuhn L, Semrau K, Sinkala M, Kankasa C, et al. High concentrations of interleukin 15 in breast milk are associated with protection against postnatal HIV transmission. J Infect Dis 2009; 200: 1498-1502.
34. Ahmad A, Ahmad R, Toma E, Morisset R, Menezes J. Impaired induction of IL-15 in response to herpes simplex virus type 1 infection in peripheral blood mononuclear cells of HIV-infected patients. AIDS 2000; 14: 744-746.
35. Oliva A, Kinter AL, Vaccarezza M, Rubbert A, Catanzaro A, Moir S, et al. Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro. J Clin Invest 1998; 102: 223-231.
36. Pereira LA, Bentley K, Peeters A, Churchill MJ, Deacon NJ. A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter. Nucleic Acids Res 2000; 28: 663-668.
37. Taggart CC, Cryan S-A, Weldon S, Gibbons A, Greene CM, Kelly E, et al. Secretory leucoprotease inhibitor binds to NFkappaB binding sites in monocytes and inhibits p65 binding. J Exp Med 2005; 202: 1659-1668.
38. Legrand FA, Nixon DF, Loo CP, Ono E, Chapman JM, Miyamoto M, et al. Strong HIV-1-specific T cell responses in HIV-1-exposed uninfected infants and neonates revealed after regulatory T cell removal. PLoS One 2006; 1: e102.
39. Kourtis AP, Lee FK, Abrams EJ, Jamieson DJ, Bulterys M. Mother-To-child transmission of HIV-1: timing and implications for prevention. Lancet Infect Dis 2006; 6: 726-732.
40. Viard M, Parolini I, Sargiacomo M, Fecchi K, Ramoni C, Ablan S, et al. Role of cholesterol in human immunodeficiency virus type 1 envelope protein-mediated fusion with host cells. J Virol 2002; 76: 11584-11595.